Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2010-07-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control and exercise
this is trained and receives placebo
exercise training
resistance training twice a week for 24 weeks
placebo (dextrose)
20g/d for 7 days followed by 5g/d for 23 weeks
creatine
this is non-exercise trained and receives creatine supplementation
creatine supplementation
20g/d for 7 days followed by 5g/d for 23 weeks
exercise and creatine
this is exercised trained and receives creatine supplementation
creatine supplementation
20g/d for 7 days followed by 5g/d for 23 weeks
exercise training
resistance training twice a week for 24 weeks
placebo
this only receives placebo (dextrose)
placebo (dextrose)
20g/d for 7 days followed by 5g/d for 23 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
creatine supplementation
20g/d for 7 days followed by 5g/d for 23 weeks
exercise training
resistance training twice a week for 24 weeks
placebo (dextrose)
20g/d for 7 days followed by 5g/d for 23 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women older than 60 years old
Exclusion Criteria
* drugs affecting bone metabolism
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Gualano
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosa MR Pereira, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Bruno Gualano, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Medicine - Division of Rheumatology
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
creatine and bone
Identifier Type: -
Identifier Source: org_study_id